Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002085 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy
A NA study, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
NCT00002085: Completed NA study, sponsored by Pfizer.
NCT00002085 is a NA study that has completed, run by Pfizer. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002085, a NA study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To evaluate the efficacy and safety of azithromycin given chronically for the treatment of serious nontuberculous mycobacterial infection in patients failing or intolerant of other available therapy.
Interventions
- DRUG Azithromycin
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002085 record still lists
NCT00002085 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Azithromycin is the first listed.
NCT00002085 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002085 about?
NCT00002085 is a clinical study titled "A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy". To evaluate the efficacy and safety of azithromycin given chronically for the treatment of serious nontuberculous mycobacterial infection in patients failing or intolerant of other available therapy.
What is the current status of trial NCT00002085?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002085?
The interventions under investigation include: Azithromycin (DRUG).
Who is sponsoring clinical trial NCT00002085?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.